SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression

被引:4
作者
Li, Zhihan [1 ]
Xi, Jinchuan [1 ]
Li, Baokun [1 ]
Liu, Youqiang [1 ]
Wang, Guiying [1 ,2 ]
Yu, Bin [1 ]
Ma, Hongqing [1 ]
Li, Zhilin [3 ]
Zhang, Zhenya [1 ]
机构
[1] Fourth Hosp Hebei Med Univ, Dept Gen Surg, Shijiazhuang, Peoples R China
[2] Third Hosp Hebei Med Univ, Dept Gastrointestinal Surg, Shijiazhuang, Peoples R China
[3] Hebei Med Univ, Sch Basic Med, Shijiazhuang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
Src homology region 2 domain-containing protein tyrosine phosphatase-2; tumor-associated macrophages; colorectal cancer; migration; invasion; TYROSINE-PHOSPHATASE SHP-2; TRIGGERS ANTITUMOR IMMUNITY; COLON-CANCER; EXPRESSION; PTPN11; MUTATIONS; CELLS;
D O I
10.3389/fonc.2023.1027575
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo explore the effect and molecular mechanism of Src homology region 2 domain-containing protein tyrosine phosphatase-2 (SHP-2) in tumor-associated macrophages (TAMs) repressing the migration and invasion of colorectal cancer (CRC) cells. MethodsThe relevant data sets of human colon specimens were obtained from GEO database, and then the performed correlation analysis, principal component analysis and differentially expressed gene (DEGs) analysis on the samples were conducted. GO and KEGG enrichment analysis were performed on the common DEGs, and then functional interaction prediction was performed to verify the gene regulatory circuit of SHP-2. Furthermore, western blot was used to detect the effect of low expression of SHP-2 on related proteins, including the markers of promoting M2 polarization and exosome secretion, and keys proteins of the PI3K pathway. The relationship between SHP-2 and PI3K pathway was further verified by adding PI3K inhibitor LY294002. Finally, the effect of SHP-2 on the function of colon cancer cells was confirmed by wound healing assay and Transwell assay. ResultsThrough bioinformatics analysis, SHP-2 was screened as a possible key gene affecting CRC. The low expression of SHP-2 promoted the protein levels of Arginase-1 and IL-10 in IL-4 induced M2 macrophages, while inhibited the protein levels of IL-1 beta and TNF-alpha. Meanwhile, low expression of SHP-2 was found to similarly promote the expression of p-PI3K, p-AKT, and the release of exosomes. Interestingly, the promotion was suppressed after the addition of the PI3K inhibitor LY294002. In terms of cellular behavior, wound healing and transwell data showed that low expression of SHP-2 enhanced the migration and invasion abilities of CRC cells. ConclusionThe low expression of SHP-2 induced by PHPS1 may regulate M2 polarization of TAMs and release of exosomes through PI3K/AKT pathway, thereby enhancing the migration and invasion ability of CRC cells.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
    Ding, Ling
    Liang, Guikai
    Yao, Zhangting
    Zhang, Jieqiong
    Liu, Ruiyang
    Chen, Huihui
    Zhou, Yulu
    Wu, Honghai
    Yang, Bo
    He, Qiaojun
    ONCOTARGET, 2015, 6 (34) : 36441 - 36455
  • [42] BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer
    Martinez, Victor G.
    Rubio, Carolina
    Martinez-Fernandez, Monica
    Segovia, Cristina
    Lopez-Calderon, Fernando
    Garin, Marina I.
    Teijeira, Alicia
    Munera-Maravilla, Ester
    Varas, Alberto
    Sacedon, Rosa
    Guerrero, Felix
    Villacampa, Felipe
    de la Rosa, Federico
    Castellano, Daniel
    Lopez-Collazo, Eduardo
    Paramio, Jesus M.
    Vicente, Angeles
    Duenas, Marta
    CLINICAL CANCER RESEARCH, 2017, 23 (23) : 7388 - 7399
  • [43] M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer
    Shu, Yuxin
    Qin, Menghao
    Song, Yue
    Tang, Qing
    Huang, Yahong
    Shen, Pingping
    Lu, Yan
    IMMUNOLOGY, 2020, 160 (04) : 345 - 356
  • [44] Ovarian cancer stem-like cells elicit the polarization of M2 macrophages
    Zhang, Qing
    Cai, Da-Jun
    Li, Bin
    MOLECULAR MEDICINE REPORTS, 2015, 11 (06) : 4685 - 4693
  • [45] M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages
    Gunassekaran, Gowri Rangaswamy
    Vadevoo, Sri Murugan Poongkavithai
    Baek, Moon-Chang
    Lee, Byungheon
    BIOMATERIALS, 2021, 278
  • [46] Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
    Sun, Zhenqiang
    Xu, Yanxin
    Shao, Bo
    Dang, Pengyuan
    Hu, Shengyun
    Sun, Haifeng
    Chen, Chen
    Wang, Chaoguan
    Liu, Jinbo
    Liu, Yang
    Hu, Junhong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
  • [47] Cannabinoid Receptor-1 suppresses M2 macrophage polarization in colorectal cancer by downregulating EGFR
    Deng, You-Ming
    Zhao, Cheng
    Wu, Lei
    Qu, Zhan
    Wang, Xin-Yu
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [48] The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression
    Tan, Jiahong
    Yang, Linna
    Zhao, Han
    Ai, Ying
    Ren, Li
    Zhang, Fen
    Dong, Wei
    Shi, Ru
    Sun, Dawei
    Feng, Yun
    EXPERIMENTAL CELL RESEARCH, 2022, 413 (02)
  • [49] PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway
    Cheng, Yang
    Zhu, Yun
    Xu, Jiajia
    Yang, Min
    Chen, Peiyu
    Xu, Wanfu
    Zhao, Junhong
    Geng, Lanlan
    Gong, Sitang
    MOLECULAR CANCER, 2018, 17
  • [50] CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15
    Liu, Yixin
    Chen, Xiangzheng
    Xu, Ying
    Yang, Tinghan
    Wang, Haichuan
    Wang, Ziqiang
    Hu, Zhangyong
    Chen, Longqi
    Zhang, Zheng
    Wu, Yangping
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2024, 102 (01): : 81 - 94